Publications by authors named "Kristina Lim"

Claim this Profile
R
Recommendations From a Chinese-Language Survey of Knowledge and Prevention of Skin Cancer Among Chinese Populations Internationally: Cross-sectional Questionnaire Study.
Lily Ye Chen, Wei Niu, Kristina Lim, James A Solomon

JMIR Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Manifestations of Nutritional Deficiencies in the Context of Food Deserts of United States.
Justin P Canakis, Shane M Swink, Nicholas P Valle, Diana A Rivers, Kristina M Lim

Cureus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of Skin of Color Content on TikTok.
Kayd J Pulsipher, Anthony Concilla, Colby L Presley, Melissa R Laughter, Jaclyn Anderson, Kristina Lim

JMIR Dermatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Self-Instructional Video vs. Classroom Teaching Method on Focused Assessment With Sonography in Trauma Among House Officers in University Hospital.
Mohd Hisham Isa, Kristina Lim, Mohd Johar Jaafar, Ismail Mohd Saiboon

Front Surg· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous ubiquitin reduces inflammatory response and preserves myocardial function 3 days post-ischemia-reperfusion injury.
Stephanie L C Scofield, Suman Dalal, Kristina A Lim, Patsy R Thrasher, Christopher R Daniels

Am J Physiol Heart Circ Physiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.
Darren R Feldman, James Hu, Tanya B Dorff, Kristina Lim, Sujata Patil

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark Robson, Kristina Lim

Clin Breast Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis